Perseus Proteomics Inc. 4882.T Stock
Perseus Proteomics Inc. Price Chart
Perseus Proteomics Inc. 4882.T Financial and Trading Overview
| Perseus Proteomics Inc. stock price | 320 JPY |
| Previous Close | 287 JPY |
| Open | 287 JPY |
| Bid | 290 JPY x N/A |
| Ask | 292 JPY x N/A |
| Day's Range | 286 - 292 JPY |
| 52 Week Range | 261 - 463 JPY |
| Volume | 48.9K JPY |
| Avg. Volume | 77.7K JPY |
| Market Cap | 3.45B JPY |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -95.58 JPY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4882.T Valuation Measures
| Enterprise Value | 941.76M JPY |
| Trailing P/E | N/A |
| Forward P/E | 14.477612 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 36.580353 |
| Price/Book (mrq) | 1.4278775 |
| Enterprise Value/Revenue | 9.997 |
| Enterprise Value/EBITDA | -1.361 |
Trading Information
Perseus Proteomics Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -21.58% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 463 JPY |
| 52 Week Low | 261 JPY |
| 50-Day Moving Average | 285.94 JPY |
| 200-Day Moving Average | 328.96 JPY |
4882.T Share Statistics
| Avg. Volume (3 month) | 77.7K JPY |
| Avg. Daily Volume (10-Days) | 59.36K JPY |
| Shares Outstanding | 11.76M |
| Float | 8.78M |
| Short Ratio | N/A |
| % Held by Insiders | 17.67% |
| % Held by Institutions | 28.23% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -740.72% |
| Gross Margin | 91.85% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -14.86% |
| Return on Equity (ttm) | -28.36% |
Income Statement
| Revenue (ttm) | 94.2M JPY |
| Revenue Per Share (ttm) | 8.01 JPY |
| Quarterly Revenue Growth (yoy) | 7.59% |
| Gross Profit (ttm) | 87M JPY |
| EBITDA | -692059008 JPY |
| Net Income Avi to Common (ttm) | -786998976 JPY |
| Diluted EPS (ttm) | -65.41 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.44B JPY |
| Total Cash Per Share (mrq) | 207.91 JPY |
| Total Debt (mrq) | 0 JPY |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 22.634 |
| Book Value Per Share (mrq) | 203.799 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -564273984 JPY |
| Levered Free Cash Flow (ttm) | -600893632 JPY |
Profile of Perseus Proteomics Inc.
| Country | Japan |
| State | N/A |
| City | Tokyo |
| Address | 4-7-6, Komaba Meguro-ku |
| ZIP | 153-0041 |
| Phone | 81 3 5738 1705 |
| Website | https://www.ppmx.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Perseus Proteomics Inc., a drug discovery bio-venture company, develops antibody drugs against cancer and other diseases in Japan. The company is involved in the antibody discovery, antibody engineering, target discovery, and functional protein expression activities; and antibody research support activities comprising mouse hybridoma sequencing, recombinant protein production, and contract antibody research activities, as well as development, manufacture, and supply of antibody products. Its product pipeline includes PPMX-T001 for treating liver cancer; PPMX-T002 for solid tumors; PPMX-T003 to treat hematologic cancer; and PPMX-T004 for solid tumor. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
Q&A For Perseus Proteomics Inc. Stock
What is a current 4882.T stock price?
Perseus Proteomics Inc. 4882.T stock price today per share is 320 JPY.
How to purchase Perseus Proteomics Inc. stock?
You can buy 4882.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Perseus Proteomics Inc.?
The stock symbol or ticker of Perseus Proteomics Inc. is 4882.T.
Which industry does the Perseus Proteomics Inc. company belong to?
The Perseus Proteomics Inc. industry is Drug Manufacturers-General.
How many shares does Perseus Proteomics Inc. have in circulation?
The max supply of Perseus Proteomics Inc. shares is 11.83M.
What is Perseus Proteomics Inc. Price to Earnings Ratio (PE Ratio)?
Perseus Proteomics Inc. PE Ratio is now.
What was Perseus Proteomics Inc. earnings per share over the trailing 12 months (TTM)?
Perseus Proteomics Inc. EPS is -95.58 JPY over the trailing 12 months.
Which sector does the Perseus Proteomics Inc. company belong to?
The Perseus Proteomics Inc. sector is Healthcare.